Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07792395 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ginger's Therapeutic Potential in Asthma

Name: Ginger's Therapeutic Potential in Asthma — clinical trial record (NCT07792395)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GINGER

StatusNot Yet Recruiting

PhasePhase 2

SponsorEmily DiMango, MD

Started2026-11

View on ClinicalTrials.gov ↗

Primary Objective: The primary endpoint is a clinically significant improvement in tolerance to inhaled methacholine (PD20). Secondary Objectives: 1) To determine if oral daily ginger extract intake - decreases fractional excretion of nitric oxide; decreases blood eosinophilia; decreases asthma-associated cytokines in serum; decreases medium chain fatty acids; improves asthma symptoms; and 2) Establish pharmacokinetic parameters of biologically active components of ginger in adult asthmatics.

Trial Details

NCT Number	NCT07792395
Lead Sponsor	Emily DiMango, MD Collaborators: National Center for Complementary and Integrative Health (NCCIH)
Conditions	Asthma
Enrollment	32 participants
Start Date	2026-11
Primary Completion	2028-12 (estimated)
Study Completion	2029-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-28